In addition, the GR levels were significantly reduced in the high-grade (vs. the low-grade) or the muscle-invasive (vs. the non-muscle-invasive) bladder tumors, while such significant differences were not seen in the upper urinary tract tumors. The gene discussed is NR3C1; the disease is urinary bladder neoplasm.